Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R.

Am J Cardiol. 2005 Jan 1;95(1):13-9.

PMID:
15619387
2.

Risk prediction of contrast-induced nephropathy.

McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J; CIN Consensus Working Panel.

Am J Cardiol. 2006 Sep 18;98(6A):27K-36K. Epub 2006 Feb 23. Review.

PMID:
16949378
3.

Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.

McCullough P.

Catheter Cardiovasc Interv. 2006 Mar;67(3):335-43. Review.

PMID:
16489569
4.

The clinical and renal consequences of contrast-induced nephropathy.

Finn WF.

Nephrol Dial Transplant. 2006 Jun;21(6):i2-10. Review.

PMID:
16723349
5.

Epidemiology of contrast-induced nephropathy.

McCullough PA, Sandberg KR.

Rev Cardiovasc Med. 2003;4 Suppl 5:S3-9. Review.

PMID:
14668704
6.

Epidemiology and prognostic implications of contrast-induced nephropathy.

McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J; CIN Consensus Working Panel.

Am J Cardiol. 2006 Sep 18;98(6A):5K-13K. Epub 2006 Feb 10.

PMID:
16949375
7.

The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

Cavusoglu E, Chhabra S, Marmur JD, Kini A, Sharma SK.

Minerva Cardioangiol. 2004 Oct;52(5):419-32. Review.

8.

The clinical epidemiology of contrast-induced nephropathy.

Parfrey P.

Cardiovasc Intervent Radiol. 2005;28 Suppl 2:S3-11. Review.

PMID:
16419277
9.
10.

Understanding the consequences of contrast-induced nephropathy.

Nikolsky E, Mehran R.

Rev Cardiovasc Med. 2003;4 Suppl 5:S10-8. Review.

PMID:
14668705
11.

Prevention and treatment of contrast-associated nephropathy in interventional cardiology.

Caixeta A, Nikolsky E, Mehran R.

Curr Cardiol Rep. 2009 Sep;11(5):377-83. Review.

PMID:
19709498
12.

Contrast-induced nephropathy in invasive cardiology.

Perrin T, Descombes E, Cook S.

Swiss Med Wkly. 2012 Jun 19;142:w13608. doi: 10.4414/smw.2012.13608. Review.

13.

Risk factors for contrast-induced nephropathy.

Toprak O, Cirit M.

Kidney Blood Press Res. 2006;29(2):84-93. Epub 2006 May 16. Review.

15.

Contrast-Induced Nephropathy: An "All or None" Phenomenon?

Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP.

Angiology. 2015 Jul;66(6):508-13. doi: 10.1177/0003319714550309. Epub 2014 Sep 14. Review.

PMID:
25225196
16.

Contrast-induced nephropathy: do statins offer protection?

Sadat U.

Curr Opin Cardiol. 2011 Jul;26(4):334-7. doi: 10.1097/HCO.0b013e3283470340. Review.

PMID:
21537166
17.

Physicochemical properties of radiographic contrast media, potential nephrotoxicity and prophylaxis.

Hogstrom B, Ikei N.

Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1251-7. doi: 10.1111/1440-1681.12487. Review.

PMID:
26743677
18.

Race and contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization.

Chawla R, Turlington J, Arora P, Jovin IS.

Int J Cardiol. 2017 Mar 1;230:610-613. doi: 10.1016/j.ijcard.2016.12.046. Epub 2016 Dec 23. Review.

PMID:
28040287
19.

Intravenous Contrast: Friend or Foe? A Review on Contrast-Induced Nephropathy.

Do C.

Adv Chronic Kidney Dis. 2017 May;24(3):147-149. doi: 10.1053/j.ackd.2017.03.003. Review.

PMID:
28501076

Supplemental Content

Support Center